Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$33.62
+4.25%
Mkt Cap $2.35B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (15 analysts)
$53.80
Range $42.00 – $74.00
Implied Upside
+60.0%
Consensus $53.80 vs current $33.62
NASDAQ·Healthcare·Biotechnology
$33.62
+4.25%
Mkt Cap $2.35B
Buy
4
Hold
0
Sell
0
Price Target (15 analysts)
$53.80
Range $42.00 – $74.00
+60.0%
Consensus $53.80 vs current $33.62